A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain)

Annals of Microbiology

Volumn 54, Issue 2, 2004, Pages 227-232

  Sorlozano A ^a   Gutierrez J ^a   Fernandez F ^a   Soto, M J ^a   Piedrola G ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Antimicrobial agent; Beta lactamases; Enterobacteriaceae; Escherichia coli

Indexed keywords

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

EID: 3242722486     PISSN: 15904261     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev., 14: 933-951.
2. Cantón R., Oliver A., Coque T.M., Varela M.C., Pérez J.C., Baquero F. (2002). Epidemiology of extended-spectrum beta-lactamase producing Enterobacter isolates in a Spanish hospital during a 12-year period. J. Clin. Microbiol., 40: 1237-1243.
3. Cantón R., Pérez-Vázquez M., Oliver A., Sánchez Del Saz B., Gutiérrez M.O., Martinez-Ferrer M., Baquero F. (2000). Evaluation of the Wider System, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J. Clin. Microbiol., 38: 1339-1346.
4. Daza R., Gutiérrez J., Piédrola G. (2001). Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int. J. Antimicrob. Agent, 18: 211-215.
5. rd I.C.A.A.C. Abstract C2-57. Chicago.
6. Jarlier V., Nicolas M.H., Fournier G., Philippon A. (1988). Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10: 867-878.
7. Knothe H., Shah P., Krcméry V., Antal M., Mitsuhashi S. (1983). Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection, 11: 315-317.
8. Leverstein-van Hall M.A., Fluit A.C., Paauw A., Box A.T.A., Brisse S., Verhoef J. (2002). Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multirresistant Escherichia coli and Klebsiella spp. J. Clin. Microbiol., 40: 3703-3711.
9. Livermore D.M. (1995). β-Lactamase in laboratory and clinical resistance. Clin. Microbiol. Rev., 8: 557-584.
10. Livermore D.M., Struelens M., Amorim J., Baquero F., Bille J., Canton R., Henning S., Gatermann S., Marchese A., Mittermayer H., Nonhoff C., Oakton K.J., Praplan F., Ramos H., Schito G.G., Van Eldere J., Verhaegen J., Verhoef J. (2002). Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J. Antimicrob. Chemother., 49: 289-300.
11. Sabaté M., Miró E., Navarro F., Verges C., Aliaga R., Mirelis B., Prats G. (2002). βLactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J. Antimicrob. Chemother., 49: 989-997.
12. Sanders C.C., Barry A.L., Washington J.A., Shubert C., Moland E.S., Traczewski M.M., Knapp C., Mulder R. (1996). Detection of extended-spectrum- beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. J. Clin. Microbiol., 34: 2997-3001
13. Sanders C.C., Peyret M., Moland E.S., Shubert C., Thomson K.S., Boeufgras J.-M., Sanders W.E.Jr. (2000). Ability of the VITEK 2 advanced expert system to identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J. Clin. Microbiol., 38: 570-574.